Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

Affiliations

• ¹ The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
• ² EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France.
• ³ First Affiliated Hospital of Soochow University, Suzhou, China.
• ⁴ Oslo University Hospital, Rikshospitalet, Oslo, Norway.
• ⁵ Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Management Sport Cancer (MSC) Lab, Aix Marseille University (AMU), Marseille, France.
• ⁶ Saint-Louis Hospital, BMT Unit, Paris, France.
• ⁷ CHU Bordeaux, Hopital Haut-Leveque, Pessac, France.
• ⁸ HUCH Comprehensive Cancer Center, Helsinki, Finland.
• ⁹ Hôpital Henri Mondor, Creteil, France.
• ¹⁰ Erasmus MC Cancer Institute, Rotterdam, Netherlands.
• ¹¹ Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
• ¹² Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
• ¹³ Department of Hematology and Cell therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France.
• ¹⁴ Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy.
• ¹⁵ The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. hehuangyu@126.com.
• ¹⁶ EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France. mohamad.mohty@imserm.fr.
• ¹⁷ Department of Hematology and Cell therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. mohamad.mohty@imserm.fr.
• ¹⁸ EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France. gorinclaude@gmail.com.
• ¹⁹ Department of Hematology and Cell therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. gorinclaude@gmail.com.